The Goldman Sachs Group Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price

Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective reduced by equities researchers at The Goldman Sachs Group from $16.00 to $13.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a "buy" rating on the health services provider's stock. The Goldman Sachs Group's price objective points to a potential upside of 38.81% from the company's current price.

Other analysts have also recently issued research reports about the stock. Royal Bank of Canada increased their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Bank of America lifted their target price on Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research report on Wednesday, February 12th. Oppenheimer cut their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Finally, Piper Sandler reduced their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Teladoc Health has an average rating of "Hold" and an average target price of $11.26.

Remove Ads

Teladoc Health Price Performance

Shares of NYSE:TDOC traded up $0.34 during midday trading on Monday, hitting $9.37. The company had a trading volume of 13,570,159 shares, compared to its average volume of 8,469,188. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $15.95. The stock has a market cap of $1.63 billion, a price-to-earnings ratio of -1.62 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The business's 50-day simple moving average is $10.62 and its 200-day simple moving average is $9.62.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, research analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Institutional Trading of Teladoc Health

Several hedge funds have recently modified their holdings of TDOC. Point72 Asset Management L.P. grew its stake in Teladoc Health by 57.8% during the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider's stock worth $76,803,000 after purchasing an additional 3,063,172 shares in the last quarter. Maple Rock Capital Partners Inc. boosted its stake in shares of Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares during the period. Two Sigma Investments LP acquired a new position in shares of Teladoc Health during the fourth quarter worth about $18,348,000. Two Sigma Advisers LP increased its stake in shares of Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after buying an additional 1,537,094 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after buying an additional 1,029,829 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.